Except for the potential etiological role of big ET-1 in CAE, this biomarker has been found to be a poor prognosis factor in many cardiovascular diseases including atrial fibrillation, acute myocardial infarction, and left ventricular non-compaction cardiomyopathy (8–10). Here, EDN1 is linked to acute myocardial infarction.